Suzan Shuman is a seasoned Business Unit Director for Cardiovascular, Renal, and Metabolism (CVRM) at AstraZeneca, where she leverages over 25 years of extensive experience in the pharmaceutical industry. In her current role, Suzan is instrumental in shaping and executing strategic initiatives across the Gulf...
Suzan Shuman is a seasoned Business Unit Director for Cardiovascular, Renal, and Metabolism (CVRM) at AstraZeneca, where she leverages over 25 years of extensive experience in the pharmaceutical industry. In her current role, Suzan is instrumental in shaping and executing strategic initiatives across the Gulf Cooperation Council (GCC) cluster, particularly in key markets such as Saudi Arabia and the United Arab Emirates. Her expertise in strategy development and implementation is complemented by her adeptness in sales management, particularly within the CVRM therapeutic area, where she drives sales effectiveness and product launch excellence.
At AstraZeneca, Suzan leads high-impact projects that focus on enhancing patient outcomes through innovative healthcare solutions. She is passionate about fostering a culture of collaboration and empowerment within her teams, believing that trust and confidence are foundational to achieving ambitious business objectives. By prioritizing people development, she cultivates performance-driven teams that are equipped to navigate the complexities of the pharmaceutical landscape. Her skills in negotiation, key account management, and cluster analysis enable her to identify and capitalize on emerging opportunities, ensuring that AstraZeneca remains at the forefront of the industry.
Suzan's tenacity and strategic mindset allow her to overcome obstacles while maintaining a clear focus on high-value goals. Her commitment to excellence in sales operations and hospital sales positions her as a key player in AstraZeneca's mission to deliver transformative therapies to patients in the GCC region. Through her leadership, Suzan continues to unleash the potential of her teams, driving sustainable growth and innovation in the ever-evolving healthcare market.
